ATHIRA PHARMA, INC. CHANGE IN CONTROL AGREEMENTChange in Control Agreement • September 17th, 2024 • Athira Pharma, Inc. • Biological products, (no disgnostic substances) • Washington
Contract Type FiledSeptember 17th, 2024 Company Industry JurisdictionThis Change in Control Agreement (the “Agreement”) is made by and between Athira Pharma, Inc., a Delaware corporation (the “Company”), and Robert Renninger (“Executive”), effective as of ________________, 2023 (the “Effective Date”).